32 filings
8-K
Translate Bio, Inc.
14 Sep 21
Completion of Acquisition or Disposition of Assets
10:12am
8-K
Translate Bio, Inc.
3 Aug 21
Tender and Support Agreement
8:03am
8-K
Translate Bio, Inc.
16 Jun 21
Departure of Directors or Certain Officers
4:48pm
8-K
Translate Bio, Inc.
20 Apr 21
Departure of Directors or Certain Officers
4:31pm
8-K
Translate Bio, Inc.
23 Mar 21
Departure of Directors or Certain Officers
4:32pm
8-K
gyf92176ww90x
25 Feb 21
Translate Bio Announces Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Progress
4:06pm
8-K
e51dikooltqb8 gjo7cm
28 Dec 20
Departure of Directors or Certain Officers
4:26pm
8-K
26ur59lm6
22 Dec 20
Departure of Directors or Certain Officers
4:30pm
8-K
r7oi 992xoiuisu
25 Aug 20
Regulation FD Disclosure
10:15am
8-K
t06wtcvcvw7kfs61
20 Jul 20
Other Events
4:17pm
8-K
7ru g9tjebs
26 Jun 20
Translate Bio Announces Pricing of Public Offering of Common Stock
4:09pm
8-K
o8xjgy
23 Jun 20
Sanofi and Translate Bio Expand Collaboration to Develop mRNA Vaccines across
6:06am
8-K
lgtbh
16 Jun 20
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
wxdq0khrefrr2wsarl
7 Apr 20
Other Events
5:27pm
8-K
peii0
27 Mar 20
Sanofi Pasteur and Translate Bio to collaborate to develop a novel mRNA vaccine candidate againstCOVID-19
6:09am
8-K
8ytxz 7f2ei
26 Mar 20
Other Events
4:45pm
8-K
dnn7q87uiirjvoeopc05
13 Jan 20
Results of Operations and Financial Condition
6:50am
8-K
jzunnxza7gfrb4a705a
12 Dec 19
Translate Bio Announces Executive Leadership Appointments
4:23pm
8-K/A
h854fmiye42
25 Oct 19
Material Impairments
4:32pm
8-K
ke5zgiat
18 Sep 19
Translate Bio Announces Pricing of Public Offering of Common Stock
4:16pm